[{"AccountsPayableCurrent_0_Q3_USD":8345000.0,"PreferredStockValue_0_Q3_USD":0.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"PreferredStockSharesAuthorized_0_Q3_shares":5000000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.01,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":1198000.0,"PaymentsToAcquireOtherPropertyPlantAndEquipment_3_Q3_USD":1200000.0,"PaymentsToAcquireInvestments_3_Q3_USD":28880000.0,"PaymentsForRepurchaseOfCommonStock_3_Q3_USD":2675000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":120000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":11000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":1481000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3_Q3_USD":1000.0,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":36705000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q3_USD":0.0,"OtherAssetsCurrent_0_Q3_USD":3064000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":1465000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":2500000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":1027000.0,"OperatingLeaseLiability_0_Q3_USD":2508000.0,"OperatingIncomeLoss_3_Q3_USD":-61760000.0,"OperatingIncomeLoss_1_Q3_USD":-22962000.0,"OperatingExpenses_3_Q3_USD":62044000.0,"OperatingExpenses_1_Q3_USD":22985000.0,"NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1_3_Q3_USD":1.1,"NetIncomeLoss_3_Q3_USD":-62147000.0,"NetIncomeLoss_1_Q3_USD":-23122000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-64189000.0,"OtherAssetsNoncurrent_0_Q3_USD":2471000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-3986000.0,"ProceedsFromSaleMaturityAndCollectionsOfInvestments_3_Q3_USD":26092000.0,"PropertyPlantAndEquipmentGross_0_Q3_USD":6160000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":144558000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":145820000.0,"UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_3_Q3_USD":-62147000.0,"UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_1_Q3_USD":-23122000.0,"TreasuryStockValue_0_Q3_USD":7518000.0,"TreasuryStockShares_0_Q3_shares":1165000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q3_USD":658000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q3_USD":19123000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_3_Q3_shares":281000.0,"StockIssuedDuringPeriodSharesNewIssues_1_Q3_shares":4177000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q3_USD":136603000.0,"StockholdersEquity_0_Q3_USD":136603000.0,"ShortTermLeaseCommitmentAmount_0_Q3_USD":1000000.0,"ProceedsFromSaleOfProductiveAssets_3_Q3_USD":0.0,"ShortTermInvestments_0_Q3_USD":28800000.0,"ShareBasedCompensation_3_Q3_USD":8349000.0,"RoyaltyIncomeNonoperating_3_Q3_USD":284000.0,"RoyaltyIncomeNonoperating_1_Q3_USD":23000.0,"Revenues_3_Q3_USD":284000.0,"Revenues_1_Q3_USD":23000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":0.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":0.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-1462165000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":38548000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":15682000.0,"RepaymentsOfLongTermDebt_3_Q3_USD":0.0,"RealizedInvestmentGainsLosses_3_Q3_USD":0.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":1311000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3_Q3_USD":4.31,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":34030000.0,"LongTermDebtCurrent_0_Q3_USD":11693000.0,"LongTermDebtAndCapitalLeaseObligations_0_Q3_USD":1481000.0,"DebtInstrumentFairValue_0_Q3_USD":11900000.0,"CostOfGoodsAndServicesSold_3_Q3_USD":0.0,"CostOfGoodsAndServicesSold_1_Q3_USD":0.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-62146000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-23122000.0,"CommonStockValue_0_Q3_USD":150000.0,"CommonStockSharesIssued_0_Q3_shares":149987000.0,"CommonStockSharesAuthorized_0_Q3_shares":225000000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.001,"CommitmentsAndContingencies_0_Q3_USD":null,"CashAndCashEquivalentsPeriodIncreaseDecrease_3_Q3_USD":-34145000.0,"CashAndCashEquivalentsFairValueDisclosure_0_Q3_USD":92118000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":92118000.0,"DepreciationDepletionAndAmortization_3_Q3_USD":180000.0,"AvailableForSaleSecurities_0_Q3_USD":28800000.0,"Assets_0_Q3_USD":172330000.0,"AssetImpairmentCharges_3_Q3_USD":0.0,"AssetImpairmentCharges_1_Q3_USD":0.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":10615.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":10615.0,"AmortizationOfFinancingCostsAndDiscounts_3_Q3_USD":46000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":2712000.0,"AdditionalPaidInCapital_0_Q3_USD":1606142000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":-6000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":4849000.0,"AccruedLiabilitiesCurrentAndNoncurrent_0_Q3_USD":14208000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":14208000.0,"AccountsReceivableNetCurrent_0_Q3_USD":23000.0,"AssetsCurrent_0_Q3_USD":124005000.0,"DilutiveSecurities_1_Q3_USD":0.0,"DilutiveSecurities_3_Q3_USD":0.0,"EarningsPerShareBasic_1_Q3_USD":-0.16,"LiabilitiesCurrent_0_Q3_USD":34246000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":172330000.0,"Liabilities_0_Q3_USD":35727000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":386000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":1163000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":531000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q3_USD":544000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":286000.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_Q3_USD":370000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":2894000.0,"InvestmentsFairValueDisclosure_0_Q3_USD":120918000.0,"InterestPaidNet_3_Q3_USD":307000.0,"InterestExpense_3_Q3_USD":507000.0,"InterestExpense_1_Q3_USD":171000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_3_Q3_shares":0.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q3_shares":0.0,"IncrementalCommonSharesAttributableToConversionOfDebtSecurities_3_Q3_shares":0.0,"IncrementalCommonSharesAttributableToConversionOfDebtSecurities_1_Q3_shares":0.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":-1985000.0,"IncreaseDecreaseInOtherOperatingAssets_3_Q3_USD":-459000.0,"IncreaseDecreaseInInventories_3_Q3_USD":0.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":-372000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_3_Q3_USD":-13433000.0,"Goodwill_0_Q3_USD":44543000.0,"GainsLossesOnExtinguishmentOfDebt_3_Q3_USD":0.0,"GainsLossesOnExtinguishmentOfDebt_1_Q3_USD":0.0,"EarningsPerShareDiluted_3_Q3_USD":-0.43,"EarningsPerShareDiluted_1_Q3_USD":-0.16,"EarningsPerShareBasic_3_Q3_USD":-0.43,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":145820000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":144558000.0,"Ticker":"LXRX","CIK":"1062822","name":"LEXICON PHARMACEUTICALS, INC.","OfficialName":"Lexicon Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"332097683.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20211109"}]